Showing 1 - 10 of 40,687
The 2011 America Invents Act was the most significant reform to the United States patent system in over fifty years …. However, the AIA did not address a number of major problems associated with patent litigation in the United States. In this … paper, we provide an economic analysis of post-AIA developments relating to Patent Assertion Entities (PAEs) and Standard …
Persistent link: https://www.econbiz.de/10014135369
The 2011 America Invents Act was the most significant reform to the United States patent system in over fifty years …. However, the AIA did not address a number of major problems associated with patent litigation in the United States. In this … paper, we provide an economic analysis of post-AIA developments relating to Patent Assertion Entities (PAEs) and Standard …
Persistent link: https://www.econbiz.de/10012456991
Persistent link: https://www.econbiz.de/10011417741
Persistent link: https://www.econbiz.de/10011534919
Persistent link: https://www.econbiz.de/10012241005
Persistent link: https://www.econbiz.de/10000143206
Persistent link: https://www.econbiz.de/10002124436
In this paper, we study the determinants of patent quality and volume of patent applications when inventors care about … perceived patent quality. We analyze the effects of various policy reforms, specifically, a proposal to establish a two …-tiered patent system. In the two-tiered system, applicants can choose between a regular patent and a more costly, possibly more …
Persistent link: https://www.econbiz.de/10014183618
To study how governments can improve the quality of patent screening, we develop an integrative framework incorporating … four main policy instruments: patent office examination, pre- and post-grant fees, and challenges in the courts. We show …. Simulations of the model, calibrated on U.S. patent and litigation data, indicate that patenting is socially excessive and the …
Persistent link: https://www.econbiz.de/10014123802
which are under patent protection in India. The Indian prices of DPP-4 inhibitors are higher than those of other drugs in … the same segment, but only a fraction of the price in the U.S. and other developed countries (i.e., the patent holders … practice international differential pricing). The patent holders also license the products out voluntarily to local …
Persistent link: https://www.econbiz.de/10013035611